Screening method for elastic fiber increasing agents
A screening method utilizing HIF-1 activity enhancement identifies agents that increase elastic fibers, addressing the complexity and inefficiency of existing methods, effectively preventing and improving skin aging symptoms.
Patent Information
- Application Number
- JP2021055124
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-03-29
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-03-29
AI Technical Summary
Existing methods for detecting and increasing elastic fibers in the skin are complicated and expensive, and there is a need for a simpler and more efficient method to evaluate agents that can promote elastic fiber formation and improve skin aging symptoms such as wrinkles and sagging.
A screening method using HIF-1 activity enhancement as an indicator to evaluate agents that increase elastic fibers by measuring the expression levels of components related to elastic fiber formation, such as elastin, fibrillin, fibulin, and lysyl oxidase, without the need for complex fiber staining operations.
The method allows for the efficient screening of substances that enhance elastic fiber formation, effectively preventing and improving skin aging symptoms by increasing the number of dermal fibers, wrinkles, and firmness, using HIF-1 activity as an indicator.
Smart Images

Figure 0007581109000007 
Figure 0007581109000008 
Figure 0007581109000009
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for screening for an agent for increasing elastic fiber and an agent for preventing or improving wrinkle formation, sagging, and loss of firmness, using enhancement of hypoxia inducible transcription factor-1 (HIF-1) activity as an indicator, and further relates to a method for screening for an agent for enhancing HIF-1 activity. [Background technology]
[0002] As we age, the skin loses elasticity, resulting in changes such as loss of firmness, wrinkles, and sagging. The skin is mainly divided into three layers: the epidermis, dermis, and subcutaneous tissue. The dermis in particular plays an extremely important role in maintaining the structure of skin tissue. The dermis is a tissue with a structure in which dermal constituent fibers such as collagen fibers and elastic fibers (elastin fibers) form a complex network. These fibers are formed by the extracellular polymerization of precursor proteins produced by fibroblasts present in the dermis. In particular, elastic fibers are important structures for the elasticity and flexibility of the skin, and their main component is elastin. Elastin is formed by the assembly and accumulation of the precursor protein tropoelastin on microfibrils made of fibrillin, and cross-linking polymerization by enzymes such as lysyl oxidase. In addition, elastic fiber formation promoting factors such as fibulin contribute to the formation of elastic fibers by promoting the assembly of tropoelastin on microfibrils. However, elastic fibers disappear with age, resulting in a decrease in skin elasticity and various aging symptoms such as wrinkles, sagging, and loss of firmness.
[0003] Therefore, agents for increasing elastic fibers have been searched for as preventive and improving agents for skin aging symptoms (Patent Documents 1 and 2). However, in order to directly detect elastic fibers, it is necessary to perform immunostaining using specific antibodies to visualize these fibers, which has the problem that the operation is complicated and the test is expensive. Therefore, instead of directly detecting elastic fibers, simple agents for increasing elastic fibers have been searched for by measuring the protein amount and gene expression level of elastin produced by fibroblasts (Patent Documents 3 and 4). However, there is a problem that even if the production amount of elastin increases, the amount of elastic fibers does not necessarily increase. Therefore, a method for evaluating the increase in elastic fibers more easily has been required.
[0004] The presence of oxygen is essential for human survival and is important for energy production in cells. On the other hand, it is known that the arterial blood oxygen pressure in the human body decreases with age, which means that aging may cause tissues in the body to be in a state of oxygen deficiency (Non-Patent Document 1). Once a cell is in a hypoxic state, a hypoxic response is induced by activation of hypoxia inducible transcription factor (HIF) (Non-Patent Document 2). HIF-1 is a transcription factor composed of subunits HIF-1α and HIF-1β, and in order to adapt to a hypoxic environment, it promotes the transcription of various proteins such as angiogenesis and glycolysis-related enzymes, causing a hypoxic response. Under normal oxygen conditions, HIF-1α is rapidly degraded in a proteasome-dependent manner by hydroxylation of proline residues by prolyl hydroxylase domain containing protein (PHD) and ubiquitination by von Hippel-Lindau, an E3 ubiquitin ligase. Therefore, under normal oxygen conditions, the amount of HIF-1α present in the cells is kept extremely low, and its transcriptional activity is suppressed. On the other hand, under hypoxic conditions, oxygen-dependent PHD activity is reduced, and HIF-1α is not degraded, its amount increases, translocates into the nucleus, and binds to HIF-1β, activating its transcription and promoting the expression of downstream genes.
[0005] Among biological tissues, the skin is considered to have few blood vessels and is chronically low in oxygen. In fact, it has been reported that the oxygen partial pressure in tissues decreases from the subcutaneous tissue deep in the skin to the dermis and epidermis on the surface of the skin, and that the oxygen partial pressure from the upper dermis to the base of the epidermis is in a hypoxic state of about 5% or less when converted to oxygen concentration (Non-Patent Document 3). For this reason, it has been reported that HIF-1 is activated in the epidermis and dermis (Non-Patent Document 4), but the relationship between HIF-1 activation and elastic fiber formation has not been known at all until now.
[0006] On the other hand, in order to evaluate HIF-1 activation, it has been common to extract HIF-1α protein from cells and evaluate its abundance. However, since HIF-1α is rapidly degraded under normal oxygen conditions, the conventional measurement of HIF-1 activity requires a very rapid extraction operation, which is not technically simple. In addition, reporter assays using vectors with HIF-1 response elements have also been performed to measure HIF-1 activity, but this requires the reporter vector to be introduced into cells from the outside, and there are limitations to the facilities that can perform this, so it is difficult to say that this is a simple method. Therefore, a more convenient means of evaluating HIF-1 activation is required. [Prior art documents] [Patent documents]
[0007] [Patent Document 1] Retable 2014 / 163178 [Patent Document 2] Special table 2014-527988 [Patent Document 3] Patent Publication No. 2012-056933 [Patent Document 4] Patent Publication 2019-189542 [Non-patent literature]
[0008] [Non-Patent Document 1] Journal of the Japanese Geriatrics Society, 1978, Vol. 15, No. 1, pp. 29-35 [Non-Patent Document 2] Biochemistry, 2013, Vol. 85, No. 3, pp. 187-195 [Non-Patent Document 3] J.Physiol..2002,538(3):985-994 [Non-Patent Document 4] Oncotarget,2014,5(22):11413-27 Summary of the Invention [Problem to be solved by the invention]
[0009] An object of the present invention is to provide a method for simply and efficiently screening for a substance capable of promoting the formation of dermal constituent fibers and preventing and / or improving wrinkle formation, sagging, and loss of firmness. [Means for solving the problem]
[0010] In order to solve the above problems, the present inventors conducted intensive research and found that the activation of HIF-1 in fibroblasts, i.e., enhancement of HIF-1 activity, increases elastic fiber. In this case, the inventors found that the gene expression levels of elastin, fibrillin constituting microfibrils, fibulin, a fibrosis-promoting factor, and lysyl oxidase, a cross-linking enzyme, increased. From these results, the inventors considered that the increase in elastic fiber would be due to the increase in the production of many components related to elastic fiber formation caused by the enhancement of HIF-1 activity. Therefore, the inventors were convinced that the enhancement of HIF-1 activity in fibroblasts could be used as an indicator to evaluate and select agents for promoting the formation of elastic fiber, and agents for preventing and improving aging symptoms such as wrinkle formation, sagging, and loss of elasticity, and thus completed the present invention.
[0011] Furthermore, the inventors have surprisingly discovered that there is an inverse correlation between HIF-1 activity and the gene expression level of HIF-1α. Specifically, they have newly discovered that when HIF-1 activity is enhanced in cells, the gene expression level of HIF-1α decreases. Therefore, they are convinced that it is possible to evaluate HIF-1 activity using the gene expression level of HIF-1α as an indicator, and have completed the present invention.
[0012] The present invention provides the following screening methods. (1) A method for screening for elastic fiber-increasing agents using enhanced hypoxia-inducible transcription factor (HIF)-1 activity as an indicator. (2) A method for screening for an agent that increases the expression of elastic fiber formation-related components using enhanced HIF-1 activity as an indicator. (3) The screening method according to (2), wherein the elastic fiber formation-related component is elastin, fibrillin, fibulin, or lysyl oxidase. (4) A method for screening for agents for preventing and improving wrinkle formation, sagging skin, and loss of elasticity, using increased HIF-1 activity as an indicator. (5) The screening method according to any one of (1) to (4), wherein the indicator of enhanced HIF-1 activity is a decrease in the expression level of HIF-1α gene. (6) A method for screening an agent for increasing elastic fiber, comprising the steps of adding a test substance or a control substance to fibroblasts and culturing the fibroblasts for an arbitrary period of time; B) measuring HIF-1 activity; C) selecting a test substance that increases HIF-1 activity in the test substance-added group compared to a test substance-free group or a control substance-added group; The method comprising: (7) A method for screening for HIF-1 activity enhancers using a decrease in the expression level of the HIF-1α gene as an indicator. Effect of the Invention
[0013] According to the present invention, by using the enhancement of HIF-1 activity in fibroblasts as an indicator, a method for screening a substance capable of increasing elastic fibers, which are fibers constituting the dermis, is provided without requiring a complicated and expensive fiber staining procedure.Furthermore, by using the expression level of HIF-1α gene as an indicator, a method for easily screening a substance that increases fibers constituting the dermis without requiring an extraction procedure of unstable HIF-1α protein, and thus a new screening method for a preventive / improving agent for wrinkle formation, sagging formation, and loss of elasticity is provided. [Brief description of the drawings]
[0014] [Figure 1] FIG. 1 shows enhanced HIF-1 activity in fibroblasts under hypoxic conditions and upon treatment with cobalt chloride (CoCl 2 ). [Diagram 2] FIG. 1 shows the expression level of HIF-1α gene in fibroblasts under hypoxic conditions and treatment with cobalt chloride (CoCl 2 ). [Diagram 3] FIG. 1 shows elastic fibers when HIF-1 activity is increased. [Figure 4] FIG. 1 shows elastic fibers when a test substance was added. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0015] A first embodiment of the screening method of the present invention is a method for evaluating and selecting a substance that can increase elastic fibers by enhancing HIF-1 activity and increasing components related to elastic fiber formation such as elastin, fibrillin, fibulin, and lysyl oxidase, thereby preventing and / or improving aging symptoms such as wrinkle formation, sagging, and loss of firmness. Specifically, the screening method includes the steps of adding a test substance or a control substance to fibroblasts and culturing them for an arbitrary period of time, measuring HIF-1 activity, and selecting a test substance that increases HIF-1 activity in the test substance-added group compared to the test substance-free group or the control substance-added group.
[0016] In a first embodiment of the screening method of the present invention, enhanced HIF-1 activity in fibroblasts is used as an index.
[0017] The HIF-1 activity enhancement of the present invention refers to a state in which HIF-1 is activated, that is, a state in which downstream genes transcribed by HIF-1 are transcriptionally activated, and since the transcription activation of downstream genes is caused by an increase in the amount of HIF-1α protein expressed in cells, it includes, for example, a state in which the proteasome-dependent degradation of HIF-1α protein in cells is inhibited and the amount of HIF-1α protein expressed in cells is increased. Downstream genes that are transcriptionally activated by HIF-1 include vascular endothelial growth factor (VEGF), erythropoietin (EPO), and other genes related to anaerobic glycolysis. The HIF-1 activity enhancer of the present invention refers to an agent that can transcriptionally activate downstream genes of HIF-1.
[0018] The term "enhancement of HIF-1 activity as an index" used in the present invention means that HIF-1 activity measured by any method is used as a standard for determining effectiveness. For example, when the presence of a test substance can increase HIF-1 activity more than a non-addition group or a control substance-addition group, it can be determined that the substance is effective. A substance that increases HIF-1 activity in fibroblasts by preferably 10% or more, more preferably 15% or more, compared to a non-addition group or a control substance-addition group, may be selected.
[0019] The method for measuring HIF-1 activity in the present invention is not particularly limited, but may be a known method, and may include, but is not limited to, measuring the transcription activity of HIF-1 downstream genes and measuring the increase in the amount of HIF-1α protein in cells. The transcription activation of HIF-1 downstream genes can be measured, for example, by quantitatively detecting the gene expression level of downstream genes that are transcriptionally activated by HIF-1 using a DNA fragment having a sequence that specifically binds to the sequence of the gene as a primer, using agarose electrophoresis or real-time PCR. Alternatively, it can be measured by introducing a vector having a HIF-1 response sequence into cells and performing a reporter assay. The increase in the amount of HIF-1α protein in cells can be measured by immunostaining, electrophoresis, Western blotting, radioimmunoassay, Enzyme-Linked ImmunoSorbent Assay (ELISA), liquid chromatography (HPLC), gas chromatography, mass spectrometry, etc., and the amount of the protein can also be indirectly measured by measuring the metabolic products of the protein. Alternatively, the amount of HIF-1α protein can be measured by introducing into cells a vector in which a tag protein, a fluorescent protein, or a gene sequence for an enzyme such as luciferase is added as a label to the gene sequence of HIF-1α protein and then performing a reporter assay. If the transcription activation of HIF-1 downstream genes or the amount of HIF-1α protein can be increased by preferably 10% or more, more preferably 15% or more, compared to a group without the test substance or a group with the control substance, it can be determined that there is an effect of enhancing HIF-1 activity.
[0020] Another method for measuring HIF-1 activity in the present invention is to measure the expression level of the HIF-1α gene.
[0021] The expression level of the HIF-1α gene can be measured by quantitative detection using agarose electrophoresis or real-time PCR using a DNA fragment having a sequence that specifically binds to the sequence of the gene as a primer. The sequences of the HIF-1α gene are publicly available, and a person skilled in the art can design appropriate primers and subject them to PCR. In addition, the expression level can be measured using known methods such as nucleic acid hybridization using solid-phase samples such as gene chips and arrays, subtraction, differential display, differential hybridization, and cross-hybridization. When the expression level of the HIF-1α gene can be reduced by preferably 10% or more, more preferably 15% or more, compared to a group without the test substance or a group with the control substance added, it can be judged that there is an action of enhancing HIF-1 activity. The method of measuring HIF-1 activity is not limited to the above.
[0022] A second embodiment of the screening method of the present invention is a method for easily measuring HIF-1 activity by using a decrease in the expression level of the HIF-1α gene in fibroblasts as an indicator, and for evaluating and selecting substances that can enhance HIF-1 activity.
[0023] The use of the reduction in the expression level of HIF-1α gene as an index in the present invention means that the expression level of HIF-1α gene measured by any method is used as the standard for determining the effect. For example, when the presence of the test substance can reduce the expression level of HIF-1α gene more than the non-addition group or the control substance-addition group, it can be determined that the test substance is effective. It is sufficient to select a substance that reduces the expression level of HIF-1α gene in fibroblasts by preferably 10% or more, more preferably 15% or more, compared to the non-addition group of the test substance or the control substance-addition group.
[0024] The fibroblast used in the present invention is not particularly limited as long as it is derived from a human or an animal. For example, fibroblasts derived from mammals such as humans, monkeys, and mice can be preferably used. The fibroblasts may be isolated from human or animal tissues, or commercially available products that have already been isolated may be used. The state of the fibroblasts to be used is not particularly limited, and the cells may be used as they are, or those that have been subjected to ultraviolet irradiation, aging treatment, etc. may also be used. For the cell culture medium, it is advisable to select a medium appropriate for the fibroblasts to be used. For example, Dulbecco's MEM (D-MEM) supplemented with 10% fetal bovine serum (FBS) can be mentioned.
[0025] The test substance used in the present invention is not particularly limited. An extract derived from animals or plants, a culture of fungi, or a processed product thereof such as an enzyme, or a compound or its derivative, etc. can be used as the test substance. It may be in a liquid state, or in a gaseous state, powder state, gel state, etc. The test substance can be added to the fibroblasts at any concentration and amount.
[0026] The culture conditions for the fibroblasts used in the present invention may generally be the same as those for culturing fibroblasts. For example, under humidified conditions of 37°C, 5% CO2, and a normal oxygen concentration (oxygen concentration of about 21%), for several hours to several days, or up to about 30 days in the case of a long period. Culture conditions that can enhance the HIF-1 activity of fibroblasts in advance may also be used, and it is also possible to culture for several hours to several days, or up to about 30 days under conditions where the oxygen concentration is set to 21% or less using nitrogen gas or a deoxidizer. In addition, the culture conditions for the fibroblasts are not particularly limited, and they may be cultured after being subjected to ultraviolet irradiation, aging treatment, etc.
[0027] Hereinafter, the present invention will be described more specifically with reference to examples, but the present invention is not limited by these examples.
Examples
[0028] <Experiment 1> The HIF-1 activity when cultured under hypoxic conditions or in the presence of cobalt chloride was measured according to the following procedure. <Measurement of HIF-1 Activity> Human dermal fibroblasts were suspended in Dulbecco's MEM (D-MEM) medium (Gibco) supplemented with 10% fetal bovine serum (Wako), and 5 × 10 4 A cell suspension was prepared at 1000 cells / mL, and 2 mL of each suspension was seeded on a 30 mm dish (Corning). The cells were cultured for 4 days at 37°C under humidified conditions of 5% CO2 / 95% air. Samples cultured under low oxygen conditions were sealed in a gas barrier pouch together with Anaeropack Kenki 5% (Mitsubishi Chemical) and an oxygen concentration meter (Sugiyamagen), adjusted to 0.1% oxygen concentration, and cultured for 1 day at 37°C under humidified conditions of 5% CO2 / 95% air. Samples cultured under normal oxygen conditions were not placed in a gas barrier pouch and cultured for 1 day at 37°C under humidified conditions of 5% CO2 / 95% air. For samples with added cobalt chloride, an aqueous solution of cobalt chloride (Wako) was added to a final concentration of 50 μM or 100 μM, and the samples were cultured for 1 day at 37°C under humidified conditions of 5% CO2 / 95% air. After the culture, the medium of each dish was removed, and the cells were dissolved by adding Sample Buffer (50 mM Tris-HCl (pH 6.8), 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.005% bromophenol blue, all from Wako). The cells were then boiled for 5 minutes to prepare samples for Western blotting. After SDS-PAGE using a 7.5% acrylamide gel, the proteins were transferred to a PVDF membrane (GE Healthcare) and reacted with a 500-fold diluted anti-HIF-1α antibody (BD Bioscience), and then with a 3000-fold diluted Horseradish peroxidase (HRP)-labeled anti-mouse antibody (GE Healthcare). The PVDF membrane was reacted with TMB substrate (Thermofisher Scientific), and chemiluminescence was detected using the iBright imaging system (Invitrogen).
[0029] As shown in Fig. 1, when fibroblasts were cultured under hypoxic conditions (0.1% oxygen), the band density of HIF-1α protein was increased compared to that cultured under normal oxygen conditions (21% oxygen), and it was confirmed that HIF-1 activity was enhanced. Also, when cobalt chloride (CoCl2) was added to fibroblasts and cultured under normal oxygen conditions, the band density of HIF-1α protein was increased compared to the non-addition group, and it was confirmed that HIF-1 activity was enhanced.
[0030] <Experiment 2> The following procedure was used to measure the expression level of the HIF-1α gene when cultured under hypoxic conditions or cobalt chloride addition conditions. <Measurement of HIF-1α Gene Expression Level> Human dermal fibroblasts were suspended in D-MEM medium (Gibco) supplemented with 10% fetal bovine serum (Wako), and 5×10 4A cell suspension was prepared to give 100 cells / mL, and 500 μL was seeded in a 24-well plate (TrueLine). The cells were cultured for 4 days at 37°C under humidified conditions of 5% CO2 / 95% air. Samples cultured under low oxygen conditions were sealed in a gas barrier pouch together with Anaeropack Kenki 5% (Mitsubishi Chemical) and an oxygen concentration meter (Sugiyamagen), adjusted to 0.1% oxygen concentration, and cultured for 1 day at 37°C under humidified conditions of 5% CO2 / 95% air. Samples cultured under normal oxygen conditions were not placed in a gas barrier pouch and cultured for 1 day at 37°C under humidified conditions of 5% CO2 / 95% air. For samples with added cobalt chloride, an aqueous solution of cobalt chloride (Wako) was added to a final concentration of 100 μM, and the samples were cultured for 1 day at 37°C under humidified conditions of 5% CO2 / 95% air. After the culture, total RNA was extracted using Total RNA Purification Kit (Jena Bioscience). Then, reverse transcription was performed using PrimeScript RT Reagent Kit (TaKaRa) to synthesize cDNA. Using the obtained cDNA as a template, the expression levels of HIF-1α and β-actin (used as housekeeping genes) were measured by real-time PCR (7500 Real-Time PCR System, Applied Biosystems) using gene-specific primers and Power SYBR Green Master Mix (Applied Biosystems), and gene expression was analyzed by the comparative Ct method. In other words, the change in gene expression level during culture under hypoxic conditions was calculated as a relative amount to the Ct value of HIF-1α in the normal oxygen condition culture group or the cobalt chloride-free group, which was corrected with the Ct value of β-actin, which was set to 1.
[0031] As shown in Figure 2, when fibroblasts were cultured under hypoxic conditions (0.1% oxygen), it was confirmed that the expression level of HIF-1α gene was reduced to about 0.4 times that of fibroblasts cultured under normal oxygen conditions (21% oxygen). In addition, when fibroblasts were cultured under normal oxygen conditions with the addition of cobalt chloride (CoCl2), it was confirmed that the expression level of HIF-1α gene was reduced to about 0.7 times that of the non-additive group.
[0032] <Experiment 3> The expression level of the HIF-1α gene and HIF-1 activity were measured when cultured under hypoxic conditions according to the following procedure. <Culture of fibroblasts under hypoxic conditions> Human dermal fibroblasts were suspended in D-MEM medium (Gibco) supplemented with 10% fetal bovine serum (Wako), and a cell suspension was prepared to a concentration of 5×10 4 cells / mL. Then, 2 mL of the cell suspension was seeded into each 30 mm dish (Corning). The cells were cultured for 4 days under humidified conditions of 37 °C, 5% CO2 / 95% air. D-MEM medium was pre-sealed in a gas barrier pouch together with AnaeroPack Kenki 5% (Mitsubishi Chemical) and an oxygen concentration meter (Sugiyama Gen), and equilibrated for 2 hours so that the oxygen concentration in the medium became 0.1% to prepare oxygen-depleted D-MEM medium. After removing the medium from the 30 mm dish and replacing it with the oxygen-depleted D-MEM medium, it was sealed in a gas barrier pouch together with AnaeroPack Kenki 5% and an oxygen concentration meter, adjusted to an oxygen concentration of 0.1%, and then cultured for 0, 3, 6, and 24 hours under humidified conditions of 37 °C, 5% CO2 / 95% air. <Measurement of HIF-1α gene expression level> After culturing, total RNA was extracted using the Total RNA Purification Kit (Jena Bioscience). Then, reverse transcription was performed using the PrimeScript RT Reagent Kit (TaKaRa) to synthesize cDNA. Using the obtained cDNA as a template, the expression levels of HIF-1α and β-actin (used as a housekeeping gene) were measured by real-time PCR (7500 Real-Time PCR System, Applied Biosystems) using gene-specific primers and Power SYBR Green Master Mix (Applied Biosystems), and the analysis of gene expression was performed by the comparative Ct method. That is, the change in the expression level of the HIF-1α gene during culture under hypoxic conditions was determined by taking the value obtained by correcting the Ct value of HIF-1α in the 0-hour hypoxia exposure group with the Ct value of β-actin as 1 and calculating the relative amount thereto. <Measurement of HIF-1 activity> After the culture, the medium of each dish was removed, and the cells were dissolved by adding Sample Buffer (50 mM Tris-HCl (pH 6.8), 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.005% bromophenol blue, all from Wako Co., Ltd.), and boiled for 5 minutes to prepare samples for Western blotting. After SDS-PAGE using 7.5% acrylamide gel, the proteins were transferred to a PVDF membrane (GE Healthcare Co., Ltd.) and reacted with a 500-fold diluted anti-HIF-1α antibody (BD Bioscience Co., Ltd.), and then with a 3000-fold diluted Horseradish peroxidase (HRP)-labeled anti-mouse antibody (GE Healthcare Co., Ltd.). The PVDF membrane was reacted with TMB substrate (Thermofisher Scientific Co., Ltd.), and chemiluminescence was detected using an iBright imaging system (Invitrogen Co., Ltd.). The band intensity of HIF-1α was quantified using ImageJ (NIH Co., Ltd.) to obtain the amount of HIF-1α protein.
[0033] As shown in Table 1, in fibroblasts cultured for 0, 3, 6, and 24 hours under hypoxic conditions, the amount of HIF-1α protein, which reflects HIF-1 activity, increased over time. On the other hand, the amount of HIF-1α gene expression in fibroblasts cultured for 0, 3, 6, and 24 hours under hypoxic conditions decreased over time. Furthermore, a Pearson correlation coefficient test confirmed that there was a significant negative correlation between the amount of HIF-1α protein and the amount of HIF-1α gene expression (correlation coefficient -0.99, p value 0.01). In other words, it was found that there is a relationship in which an increase in the amount of HIF-1α protein, that is, an increase in HIF-1 activity, leads to a decrease in the amount of HIF-1α gene expression.
[0034] [Table 1]
[0035] <Test 4> Elastic fiber formation during culture under hypoxic conditions was evaluated by the following procedure. <Detection of elastic fibers> Human dermal fibroblasts were suspended in D-MEM medium (Gibco) supplemented with 10% fetal bovine serum (Wako), and 5 × 10 4 A cell suspension was prepared to give 100 cells / mL and seeded in a 96-well plate (TrueLine) at 100 μL each. After culturing for 2 days at 37°C under humidified conditions of 5% CO2 / 95% air, the samples cultured under low oxygen conditions were sealed in a gas barrier pouch together with Anaeropack Kenki 5% (Mitsubishi Chemical) and an oxygen concentration meter (Sugiyamagen) and adjusted to a 0.1% oxygen concentration. The samples were cultured for 20 days at 37°C under humidified conditions of 5% CO2 / 95% air, with the medium replaced once every 3-4 days. The samples cultured under normal oxygen conditions were cultured for 20 days at 37°C under humidified conditions of 5% CO2 / 95% air without being placed in a gas barrier pouch. The medium was removed from each well, washed with PBS, and then permeabilization was performed for 2 minutes by adding acetone / methanol solution (both from Wako) cooled to -20°C. After washing with PBS, 3% bovine serum albumin (Wako) dissolved in PBS was added and blocking was performed at room temperature for 30 minutes. After washing, 50 μL of anti-elastin antibody (SantaCruz) diluted 50 times with 1% bovine serum albumin solution was added and reacted at room temperature for 30 minutes. After washing, 50 μL of AlexaFluor (registered trademark) 488-labeled anti-mouse antibody (Abcam) diluted 100 times with 1% bovine serum albumin solution was added and reacted at room temperature for 30 minutes. After washing, DAPI Solution (Dojindo) diluted 1000 times with PBS was added and the fluorescent image was observed with a fluorescent microscope (Keyence).
[0036] As shown in Figure 3, when fibroblasts were cultured under hypoxic conditions (0.1% oxygen) to enhance HIF-1 activity, the amount of elastin (green) fluorescence was confirmed to be higher than when they were cultured under normal oxygen conditions (21% oxygen), demonstrating an increase in elastin. Furthermore, when cultured under hypoxic conditions (0.1% oxygen), the green fluorescence was connected in a fibrous form, demonstrating that enhanced HIF-1 activity particularly promotes the formation of fibrous elastin, i.e., the formation of elastic fibers.
[0037] <Test 5> The expression levels of elastic fiber formation-related components when cultured under hypoxic conditions were evaluated by the following procedure. <Detection of components related to elastic fiber formation> Human dermal fibroblasts were suspended in D-MEM medium (Gibco) supplemented with 10% fetal bovine serum (Wako), and 5 × 10 4 The cell suspension was prepared to 1000 cells / mL and seeded in 24-well plates (TrueLine) at 500 μL each. The samples cultured under low oxygen conditions were sealed in a gas barrier pouch together with Anaeropack Kenki 5% (Mitsubishi Chemical) and an oxygen concentration meter (Sugiyamagen), adjusted to 0.1% oxygen concentration, and cultured for one day at 37°C under humidified conditions of 5% CO2 / 95% air. The samples cultured under normal oxygen conditions were not placed in a gas barrier pouch and cultured for one day under humidified conditions of 37°C and 5% CO2 / 95% air. The medium from each well was removed, and total RNA was extracted using a Total RNA Purification Kit (Jena Bioscience). Then, reverse transcription was performed using a PrimeScript RT Reagent Kit (TaKaRa) to synthesize cDNA. Using the obtained cDNA as a template, the expression levels of tropoelastin, fibrillin-1, fibulin-4, lysyl oxidase, and β-actin (used as a housekeeping gene) were measured by real-time PCR (7500 Real-Time PCR System, Applied Biosystems) using gene-specific primers and Power SYBR Green Master Mix (Applied Biosystems), and gene expression was analyzed by the comparative Ct method. In other words, the change in the expression level of each gene during culture under hypoxic conditions was calculated as the relative amount to the Ct value of each gene in the group cultured under normal oxygen conditions, which was corrected by the Ct value of β-actin, which was set to 1.
[0038] As shown in Table 2, when fibroblasts are cultured under hypoxic conditions (0.1% oxygen) to enhance HIF-1 activity, the gene expression levels of tropoelastin, fibrillin-1, fibulin-4, and lysyl oxidase, which are components related to elastic fiber formation, increase by 1.24 to 2.27 times compared to the case of culturing under normal oxygen conditions (21% oxygen).
[0039]
Table 2
[0040] <Example 1> Screening of Elastic Fiber Increasing Agent and / or HIF-1 Activity Enhancing Agent Using Decrease in HIF-1 Gene Expression Level as Index The decrease in the HIF-1α gene expression level due to the addition of the test substance was evaluated according to the following procedure. <Preparation of Test Substance> Ten times the weight of distilled water was added to the dried plant material, and the mixture was heated and extracted at 60°C for 8 hours. The extract was diluted by adding distilled water at a weight ratio of 1:99 to the dry residue of the extract, and the resulting diluted solution was used as the test substance. The plant materials used were Cynanchum acutum, Pistacia lentiscus, Anecyclus pyrethrum, Ocimum sanctum, Mentha arvensis, and Ocimum basilicum. Only the dissolution solvent of the plant material was used as the control substance. <Measurement of HIF-1α Gene Expression Level> Human dermal fibroblasts were suspended in D-MEM medium (Gibco) supplemented with 10% fetal bovine serum (Wako), and 5×10 4A cell suspension was prepared to 100 cells / mL and 500 μL was seeded in a 24-well plate (TrueLine). The cells were cultured for 4 days at 37°C under humidified conditions of 5% CO2 / 95% air. After 4 days of culture, various test substances or control substances were added to the medium at a final concentration of 20 ppm, or the positive control substance cobalt chloride (Wako) was added to a final concentration of 100 μM, and the cells were cultured for 1 day at 37°C under humidified conditions of 5% CO2 / 95% air. After culture, total RNA was extracted using a Total RNA Purification Kit (Jena Bioscience). Then, reverse transcription was performed using a PrimeScript RT Reagent Kit (TaKaRa) to synthesize cDNA. Using the obtained cDNA as a template, the expression levels of HIF-1α and β-actin (used as housekeeping genes) were measured by real-time PCR (7500 Real-Time PCR System, Applied Biosystems) using gene-specific primers and Power SYBR Green Master Mix (Applied Biosystems), and gene expression was analyzed by the comparative Ct method. In other words, the change in gene expression level due to the addition of the test substance was calculated as a relative amount to the Ct value of HIF-1α in the control substance-added group, which was corrected by the Ct value of β-actin, which was set to 1.
[0041] As shown in Table 3, in fibroblasts to which cobalt chloride (CoCl2), a positive control substance, was added, the expression level of the HIF-1α gene decreased by 28% compared to the control (Control) to which the control substance was added. In fibroblasts to which Japanese butterbur extract, pistachio extract, mint extract, and basil extract were added, the expression level of the HIF-1α gene hardly changed compared to the control with the addition of the control substance. In contrast, in fibroblasts to which anacardium extract and holy basil extract were added, the expression level of the HIF-1α gene decreased by about 11% - 13% compared to the control with the addition of the control substance. That is, it can be determined that anacardium extract and holy basil extract have sufficient effects on enhancing the HIF-1 activity of fibroblasts, and this method can be used to select an HIF-1 activity enhancer and / or an elastic fiber increasing agent for fibroblasts. By using this screening method, it is possible to select substances that prevent and improve wrinkle formation, sagging, and loss of firmness by enhancing HIF-1 activity and increasing elastic fibers.
[0042]
Table 3
[0043] <Example 2> Screening of Elastic Fiber Increasing Agents Using HIF-1 Activity Enhancement as an Index The HIF-1 activity by the addition of the test substance was measured according to the following procedure. <Preparation of Test Substance> The same procedure as in Example 1 was performed. <Measurement of HIF-1 Activity> Human dermal fibroblasts were suspended in D-MEM medium (Gibco) supplemented with 10% fetal bovine serum (Wako), and 5×10 4A cell suspension was prepared to give a cell concentration of 100 μL per well, and seeded in a 96-well plate (TrueLine). After culturing for 4 days at 37°C under humidified conditions of 5% CO2 / 95% air, various test substances or control substances were added to the medium at a final concentration of 50 ppm, or positive control substance cobalt chloride (CoCl2) was added to a final concentration of 100 μM, and cultured for 1 day at 37°C under humidified conditions of 5% CO2 / 95% air. The medium was removed from each well, and 4% paraformaldehyde (Wako) dissolved in phosphate buffered saline (PBS) was added and left to stand at room temperature for 20 minutes to perform fixation. After washing with PBS, 0.1% TritonX-100 (registered trademark, MP Biomedicals) dissolved in PBS was added to each well and left to stand at room temperature for 10 minutes. After washing, 1% hydrogen peroxide dissolved in PBS was added to each well and left to stand at room temperature for 10 minutes. After washing, the wells were blocked with 1.25% skim milk (Wako), and anti-HIF-1α antibody (GeneTex) diluted 250-fold with 1% skim milk solution was added to each well, and then reacted at 4°C overnight. After washing, Horseradish peroxidase (HRP)-labeled anti-rabbit antibody (GE Healthcare) diluted 800-fold with 1% skim milk solution was added to each well, and reacted at room temperature for 1 hour. After washing, 100 μL of TMB substrate (Thermofisher Scientific) was added to each well, incubated at 37°C for 10 minutes, and then an equal amount of 2N sulfuric acid was added. The absorbance (A) at 450 nm was measured using a fluorescent plate reader (TECAN). The solution was removed, and each well was washed three times with 0.1% Tween-20 (registered trademark, ICI) dissolved in PBS, washed once with PBS, and then the plate was air-dried. 50μL of 0.1% crystal violet (Wako) solution dissolved in PBS was added to each well and stained at room temperature for 30 minutes. After washing each well with running water and PBS, 100μL of 1% sodium dodecyl sulfate (Wako) dissolved in PBS was added and shaken at room temperature for 1 hour to dissolve the crystal violet, and the absorbance (B) at 595nm was measured using a fluorescent plate reader. HIF-1 activity was calculated according to formula 1.
[0044]
number
[0045] As shown in Table 4, in fibroblasts to which cobalt chloride (CoCl2) was added as a positive control substance, the amount of HIF-1α was increased by 42% compared to the control to which the control substance was added. In fibroblasts to which mint extract and basil extract were added, the amount of HIF-1α was almost unchanged compared to the control to which the control substance was added, whereas in fibroblasts to which Anneke pea extract and Holy basil extract were added, the amount of HIF-1α was increased by 16% and 27%, respectively. In other words, it can be determined that Anneke pea extract and Holy basil extract have sufficient HIF-1 activity enhancing effect in fibroblasts, and this method can be used to select an elastic fiber increasing agent. By using this screening method, it is possible to select a substance that enhances HIF-1 activity and increases elastic fibers, thereby preventing and improving wrinkle formation, sagging formation, and loss of firmness.
[0046] [Table 4]
[0047] <Example 3> Confirmation of the effect of adding test substance on increasing dermal fiber formation Elastic fiber formation due to the addition of the test substance was evaluated by the following procedure. <Preparation of test substance> The same procedure as in Example 1 was followed. <Detection of elastic fibers> Human dermal fibroblasts were suspended in D-MEM medium (Gibco) supplemented with 10% fetal bovine serum (Wako), and 5 × 10 4A cell suspension was prepared at 100μL / mL and seeded in a 96-well plate (TrueLine). After 2 days of culture at 37℃, 5%CO2 / 95% air, various test substances or control substances were added to the medium at a final concentration of 50ppm. The medium was replaced once every 3-4 days and cultured at 37℃, 5%CO2 / 95% air, for 20 days. Samples cultured under normal oxygen conditions were cultured at 37℃, 5%CO2 / 95% air, for 20 days without being placed in a gas barrier pouch. After removing the medium from each well and washing with PBS, acetone / methanol solution (both Wako) cooled to -20℃ was added and permeabilization was performed for 2 minutes. After washing with PBS, 3% bovine serum albumin (Wako) dissolved in PBS was added and blocking was performed at room temperature for 30 minutes. After washing, 50 μL of anti-elastin antibody (SantaCruz) diluted 50-fold with 1% bovine serum albumin solution was added and reacted at room temperature for 30 minutes. After washing, 50 μL of AlexaFluor (registered trademark) 488-labeled anti-mouse antibody (Abcam) diluted 100-fold with 1% bovine serum albumin solution was added and reacted at room temperature for 30 minutes. After washing, DAPI Solution (Dojindo) diluted 1000-fold with PBS was added, and the fluorescent image was observed with a fluorescent microscope (Keyence).
[0048] As shown in FIG. 4, when fibroblasts were cultured after adding holy basil extract, the amount of fluorescence of elastin (green) was confirmed to be increased compared to the control (control) or basil extract, and it was revealed that elastin was increased. Furthermore, when the fibroblasts were cultured after adding holy basil extract, the green fluorescence was connected in a fibrous form, which revealed that the enhancement of HIF-1 activity by holy basil extract promotes the formation of fibrous elastin, i.e., the formation of elastic fibers. In other words, it can be determined that the holy basil extract, which has been confirmed to have an effect of enhancing HIF-1 activity from Tables 3 and 4, has a sufficient effect of enhancing elastic fiber formation, and an elastic fiber increaser can be selected using this method. By using this screening method, it is possible to select a substance that enhances HIF-1 activity and increases elastic fibers, thereby preventing and improving wrinkle formation, sagging formation, and loss of firmness.
[0049] <Example 4> Confirmation of the effect of adding a test substance on increasing components related to elastic fiber formation The effect of adding a test substance on increasing the elastic fiber formation-related components was evaluated according to the following procedure. <Preparation of test substance> The same procedure as in Example 1 was followed. <Detection of components related to elastic fiber formation> Human dermal fibroblasts were suspended in D-MEM medium (Gibco) supplemented with 10% fetal bovine serum (Wako), and 5 × 10 4A cell suspension was prepared to give 100 cells / mL, and 500 μL was seeded in a 24-well plate (TrueLine). The cells were cultured for 6 days at 37°C under humidified conditions of 5% CO2 / 95% air, and various test substances or control substances were added to the medium to a final concentration of 50 ppm. After culturing for 1 day under humidified conditions of 37°C and 5% CO2 / 95% air, total RNA was extracted using a Total RNA Purification Kit (Jena Bioscience). Then, reverse transcription was performed using a PrimeScript RT Reagent Kit (TaKaRa) to synthesize cDNA. Using the obtained cDNA as a template, the expression levels of tropoelastin, fibrillin-1, fibulin-4, lysyl oxidase, and β-actin (used as a housekeeping gene) were measured by real-time PCR (7500 Real-Time PCR System, Applied Biosystems) using gene-specific primers and Power SYBR Green Master Mix (Applied Biosystems), and gene expression was analyzed by the comparative Ct method. In other words, the change in gene expression level due to the addition of the test substance was calculated as a relative amount to the Ct value of the control substance added, which was corrected by the Ct value of β-actin, which was set to 1.
[0050] As shown in Table 5, in fibroblasts to which the mint extract was added, the gene expression levels of tropoelastin, fibrillin-1, fibulin-4, and lysyl oxidase were almost unchanged compared to the control to which a control substance was added, whereas in fibroblasts to which the holy basil extract was added, the gene expression level of tropoelastin increased by 2.34 times, and the gene expression levels of fibrillin-1, fibulin-4, and lysyl oxidase increased by 1.26 to 1.45 times. In other words, it can be determined that the holy basil extract, which has been confirmed to enhance HIF-1 activity, has a sufficient effect of enhancing components related to elastic fiber formation, and this method can be used to select an elastic fiber increaser. By using this screening method, it is possible to select a substance that enhances HIF-1 activity and increases elastic fibers, thereby preventing and improving wrinkle formation, sagging, and loss of firmness.
[0051] [Table 5]
Claims
[Claim 1] A method for screening an elastic fiber increasing agent, comprising the steps of: A) adding a test substance or a control substance to fibroblasts and culturing the fibroblasts for an arbitrary period of time; B) measuring HIF-1 activity; C) selecting a test substance that increases HIF-1 activity in the test substance-added group compared to a test substance-free group or a control substance-added group; The method comprising:
Citation Information
Patent Citations
Elastin production promoter
JP2012056933A
In vivo synthesis of elastic fibers
JP2014527988A
Compositions and methods for inhibiting the activity of hypoxia-inducible transcription factor complexes, and their use for the treatment of tumors.
JP2015526516A
Elastic fiber formation promoter
JP2019189542A
New topical formulation for use in alopecia
WO2020157064A1
